Earlier today, Monday, September 22, 2014 the Chicago Mercantile Exchange Inc. (CME or Exchange) delisted the Chinese Renminbi/ Japanese Yen (RMB/JPY) Cross Rate Futures (Rulebook Chapter 319; Code RMY), the Options on Chinese Renminbi/ Japanese Yen (RMB/JPY) Cross Rate Futures (Rulebook Chapter 319A; Code RMY) from CME Globex and CME ClearPort, the venues on which they were listed. In addition, the Weekly Options on Chinese Renminbi/ Japanese Yen (RMB/JPY) Cross Rate Futures (Rulebook Chapter 319A, Codes: RN1, RN2, RN3, RN4 and RN5) were delisted from CME Globex, the venue on which they were listed. There was no open interest in these contracts.
As a result of the delisting, information regarding these contracts has been deleted from the respective product chapters, from the Position Limit, Position Accountability and Reportable Level Table in the Interpretations and Special Notices Section of Chapter 5 (Trading Qualifications and Practices), the CME Globex non-reviewable ranges in Rule 588.H, and the GCC Product Resources table in CME Rule 580 of the Exchange Rulebook, as well as the list of block-eligible products located on the CME Group website.
Please direct questions regarding this notice to:
Malcolm Baker +65 6593 5573 Malcolm.Baker@cmegroup.com
Will Patrick +44 20 3379 3721 Will.Patrick@cmegroup.com
Nigel Manthorp +44 20 3379 3863 Nigel.Manthorp@cmegroup.com
Simon Burnham +1 312 930 3426 Simon.Burnham@cmegroup.com
Craig LeVeille +1 312 454 5301 Craig.LeVeille@cmegroup.com
CME Group is the world's leading and most diverse derivatives marketplace. The company is comprised of four Designated Contract Markets (DCMs). Further information on each exchange's rules and product listings can be found by clicking on the links to CME, CBOT, NYMEX and COMEX.